Multiple drugsDrug resistance and off-label use : case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1917卷 / 1期

关键词：

D O I：

10.1007/s40278-022-20258-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：387 / 387

相关论文

共 50 条

[31] Multiple drugsLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1925 (1) : 348 - 348
[32] Multiple drugsLack of efficacy and off-label use : case report
Reactions Weekly, 2022, 1921 (1) : 191 - 191
[33] Multiple drugsQTc prolongation and off-label use: case report
Reactions Weekly, 2021, 1874 (1) : 188 - 188
[34] Multiple drugsElevated INR and off-label use: case report
Reactions Weekly, 2022, 1901 (1) : 333 - 333
[35] Multiple drugsVarious toxicities and off-label use: case report
Reactions Weekly, 2020, 1806 (1) : 202 - 202
[36] Multiple drugsLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1924 (1) : 308 - 308
[37] Multiple drugsHypoglycaemia secondary to off-label use: case report
Reactions Weekly, 2020, 1816 (1) : 228 - 228
[38] Multiple drugsLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1931 (1) : 407 - 407
[39] Multiple drugsLack of efficacy and off-label use: case report
Reactions Weekly, 2024, 2027 (1) : 307 - 307
[40] Multiple drugsLack of efficacy and off-label use : case report
Reactions Weekly, 2022, 1920 (1) : 338 - 338

← 1 2 3 4 5 →